BACKGROUND: To examine the incidence, characteristics, and outcomes for second
malignancies following the diagnosis of a primary solid tumor in pediatric patients …

BACKGROUND. The growing number of individuals surviving childhood cancer has
increased the awareness of adverse long‐term sequelae. One of the most worrisome …

To investigate the incidence and outcome of secondary neoplasms in pediatric patients
treated for childhood cancer. Between December 1971 and January 2000, a total of 5859 …

Currently, approximately 67% of children diagnosed with cancer can be expected to survive
more than 5 years. Among the most significant late effects of cancer therapy is the …

Background Increased survival in young sarcoma patients comes along with a higher
incidence of second malignant neoplasms (SMNs). The incidence, latency, histiotype, and …

BACKGROUND Survivors of childhood malignancies have an increased risk of developing
second malignant neoplasms (SMN) due to their prior treatment and/or genetic …

Background Childhood cancer survivors were at risk of development of second malignant
neoplasms. The aim of this study is to evaluate the incidence, risk factors and outcome of …

As the cure rate for childhood malignancies increases, the number of patients at risk for
development of second malignancies also increases. Due to the potentially long remaining …

Background Second malignant neoplasm is one of the most devastating late effects of
childhood cancers. This study aimed to evaluate the incidence and survival outcomes of …

Background Pediatric CNS tumors remain the most common solid tumor of childhood and
account for most cancer deaths in this group. In aggregate, more than 1000 children are …